| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.59 | 0.005 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.08 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.35 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |